Literature DB >> 20825050

Prospective clinical study of the association between plasma level of free IGF-1 and myometrial invasion min patients with endometrial adenocarcinoma.

Ali Baloglu1, Incim Bezircioglu, Burcu Cetinkaya, Levent Hicyilmaz.   

Abstract

INTRODUCTION: Endometrial carcinoma is a common malignancy of the female genital tract. There is a strong correlation between myometrial invasion and clinical prognosis. Increasing myometrial penetration is associated with an increasing risk of pelvic and para-aortic lymph node metastasis, adnexal metastasis, positive peritoneal cytology local vault recurrence, and hematogenous spread. The causal role for Insulin-like growth factor-1 and insulin in endometrial carcinogenesis is well supported and insulin and IGF system have mitogenic and antiapoptotic activity Endometrial cancer cell lines express high-affinity insulin receptors, consistent with there being a direct biological effect of insulin and IGF system on the growth and myometrial invasion of endometrial cancer cells.
MATERIAL AND METHODS: Patients with endometrial carcinoma have been divided into three groups: tumor confined to the endometrium (stage IA, n:24), endometrial carcinoma with a minimal invasion (less than 50% of the myometrium; stage IB, n:32), and the control group (n:40). Demographic factors, estradiol and free IGF-1 plasma levels have been compared in all groups.
RESULTS: Lower Free IGF-1 plasma levels were found in patients with myometrial invasion when compared to the patients without myomnetrial invasion.
CONCLUSIONS: In the following work we have presented the current understanding of endometrial carcinoma, association between free IGF-1 plasma levels and myometrial invasion in patients with endometrial adenocarcinoma in terms of management and survival.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20825050

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  2 in total

1.  Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma.

Authors:  Jieyu Wang; Nan Jia; Qing Li; Chao Wang; Xiang Tao; Keqin Hua; Weiwei Feng
Journal:  Oncol Lett       Date:  2016-07-28       Impact factor: 2.967

2.  Odds ratio analysis in women with endometrial cancer.

Authors:  Katarzyna Plagens-Rotman; Ewa Żak; Beata Pięta
Journal:  Prz Menopauzalny       Date:  2016-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.